๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Current trials and future directions of the eastern cooperative oncology group breast cancer committee

โœ Scribed by William C. Wood

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
268 KB
Volume
74
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Overview of advanced urothelial cancer t
Overview of advanced urothelial cancer trials of the Eastern Cooperative Oncology Group
โœ Robert Dreicer; Bruce Roth; George Wilding ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB ๐Ÿ‘ 1 views

Advanced transitional cell carcinoma of the urothelium is an aggressive malignancy characterized by a median survival period of less than 1 year. Although this disease is moderately chemotherapy-sensitive, to the authors' knowledge the impact of therapy reported to date on survival has been minimal.

Current NCI-sponsored Cooperative Group
Current NCI-sponsored Cooperative Group trials of endocrine therapies in breast cancer
โœ Jennifer Eng-Wong; Jo Anne Zujewski ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 2 views

Over several decades, investigators working through National Cancer Institute-sponsored Cooperative Groups have contributed to major advances in the endocrine treatment of breast cancer. Accomplishments include the benefit of tamoxifen therapy for early stage invasive and noninvasive breast cancer,

Clinical trials and drug toxicity in the
Clinical trials and drug toxicity in the elderly. The experience of the eastern cooperative oncology group
โœ Colin B. Begg; Paul P. Carbone ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 520 KB

Nineteen studies of advanced cancer in 8 disease sites have been examined using data from the Eastern Cooperative Oncology Group. The purpose of the investigation was to determine susceptibility of elderly patients (270 years of age) to cancer chemotherapy and to compare the results with correspondi